Deficient phytohemagglutinin-induced interleukin-2 activity in patients with inactive systemic lupus erythematosus is correctable by the addition of phorbol myristate acetate

Arthritis Rheum. 1988 Jul;31(7):826-33. doi: 10.1002/art.1780310702.

Abstract

In systemic lupus erythematosus (SLE) patients, the production of interleukin-2 (IL-2) by blood T lymphocytes in response to stimulation with phytohemagglutinin (PHA) either alone or with phorbol myristate acetate (PMA) or ionomycin, a Ca2+ ionophore, was examined. Deficiency in PHA-stimulated IL-2 production by cells from SLE patients was repaired by the addition of PMA, but not ionomycin. PMA alone did not stimulate IL-2 production but, in concert with PHA, induced IL-2 synthesis. Moreover, PMA was effective in the repair of the deficiency of PHA-induced IL-2 production by both T4+ and T8+ subsets. Thus, for effective IL-2 production, SLE T cells required signals either distinct from or in addition to those supplied by PHA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomechanical Phenomena
  • Ethers / pharmacology
  • Female
  • Humans
  • Interleukin-2 / biosynthesis
  • Interleukin-2 / deficiency*
  • Interleukin-2 / metabolism
  • Ionomycin
  • Lupus Erythematosus, Systemic / metabolism*
  • Lupus Erythematosus, Systemic / pathology
  • Lupus Erythematosus, Systemic / physiopathology
  • Phytohemagglutinins / pharmacology*
  • T-Lymphocytes / classification
  • T-Lymphocytes / metabolism
  • Tetradecanoylphorbol Acetate / pharmacology*

Substances

  • Ethers
  • Interleukin-2
  • Phytohemagglutinins
  • Ionomycin
  • Tetradecanoylphorbol Acetate